Pure Global

Drug test, qualitative antibody test for IgG and IgM against HBcAg - Vietnam Registration 2402950ĐKLH/BYT-HTTB

Access comprehensive regulatory information for Drug test, qualitative antibody test for IgG and IgM against HBcAg in Vietnam's medical device market through Pure Global AI's free database. This Risk Class TTBYT Loại D medical device is registered under number 2402950ĐKLH/BYT-HTTB. The authorized representative in Vietnam is CÔNG TY TNHH ROCHE VIỆT NAM.

This page provides complete technical specifications, regulatory compliance details, 1 companies making similar products including Roche Diagnostics GmbH, and 1 recent registrations in the same category. Pure Global AI offers free access to 300,000+ Vietnamese medical device registrations, helping global MedTech companies navigate Vietnam MOH regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
300,000+ Devices
1 Competitors
1 Recent Registrations
2402950ĐKLH/BYT-HTTB
Registration Details
Vietnam MOH Registration: 2402950ĐKLH/BYT-HTTB
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

Drug test, qualitative antibody test for IgG and IgM against HBcAg
VN: Thuốc thử, chất hiệu chuẩn xét nghiệm định tính kháng thể IgG và IgM kháng HBcAg
Risk Class TTBYT Loại D

Registration Details

2402950ĐKLH/BYT-HTTB

000.00.04.G18-230823-0015

Theo theo phụ lục

Theo phụ lục

Company Information

Technical Details

In vitro immunoassay for the qualitative determination of IgG and IgM antibodies against the core antigen of the hepatitis B virus in human serum and plasma. The "ECLIA" (electrochemiluminescence immunoassay "ECLIA") is used for the cobas e immunoassay analyzers.

Dates and Status

Oct 22, 2024

Companies Making Similar Products
Companies providing products similar to "Drug test, qualitative antibody test for IgG and IgM against HBcAg"